COIN shares pumped to a three-year high this week as Bitcoin spikes following Trump's election win. Analysts weigh in on ...

Oppenheimer downgraded Nice (NICE) to Perform from Outperform without a price target The company’s organic cloud growth continues to ...

Peter Oppenheimer, Goldman Sachs chief global equity strategist, joins 'Money Movers' to discuss the expected economic ...

One key factor that we can’t ignore is the continuing boom in artificial intelligence. Advances in AI technology have boosted ...

While the actor’s enthusiasm for 'Red One’s visuals is understandable, his comparison to 'Oppenheimer' has not gone over well ...

In a report released today, Francois Brisebois from Oppenheimer maintained a Hold rating on Ovid Therapeutics (OVID – Research Report).

Fans mock Dwayne Johnson on social media after comments regarding what motivated Red One's theatrical release.

Dwayne Johnson has recently revealed that the inspiration behind releasing his upcoming movie Red One in IMAX was none other ...

The film is a contemplative narrative of an Irish family man whose childhood trauma is unearthed after a routine coal ...

On Wednesday, Allogene Therapeutics Inc (ALLO) stock saw a decline, ending the day at $2.72 which represents a decrease of $-0.12 or -4.23% from the prior close of $2.84. The stock opened at $2.86 and ...

The Rock recently compared seeing Oppenheimer in an IMAX theater to going to see his new Christmas film, Red One.

Dwayne Johnson, aka 'The Rock', shared his reaction to Oppenheimer at IMAX ahead of the release of his new movie, Red One ...